Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

CDK4 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

CDK4 overexpression	Osteosarcoma	CDK4 overexpression	Osteosarcoma	palbociclib Sensitive: C2 – Inclusion Criteria palbociclib Sensitive : C2	palbociclib Sensitive: C2 – Inclusion Criteria palbociclib Sensitive : C2
CDK4 overexpression	Soft Tissue Sarcoma	CDK4 overexpression	Soft Tissue Sarcoma	palbociclib Sensitive: C2 – Inclusion Criteria palbociclib Sensitive : C2	palbociclib Sensitive: C2 – Inclusion Criteria palbociclib Sensitive : C2
CDK4 overexpression	Gastrointestinal Stromal Tumor	CDK4 overexpression	Gastrointestinal Stromal Tumor	imatinib Sensitive: C3 – Early Trials imatinib Sensitive : C3	imatinib Sensitive: C3 – Early Trials imatinib Sensitive : C3
CDK4 overexpression	Adrenal Cortex Carcinoma	CDK4 overexpression	Adrenal Cortex Carcinoma	palbociclib Sensitive: D – Preclinical palbociclib Sensitive : D	palbociclib Sensitive: D – Preclinical palbociclib Sensitive : D
CDK4 overexpression	Ependymoma	CDK4 overexpression	Ependymoma	abemaciclib Sensitive: D – Preclinical abemaciclib Sensitive : D	abemaciclib Sensitive: D – Preclinical abemaciclib Sensitive : D
CDK4 overexpression	Breast Cancer	CDK4 overexpression	Breast Cancer	palbociclib Sensitive: D – Preclinical palbociclib Sensitive : D	palbociclib Sensitive: D – Preclinical palbociclib Sensitive : D